BioGaia AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 297.77 million compared to SEK 274.28 million a year ago. Net income was SEK 67.36 million compared to SEK 139.43 million a year ago. Basic earnings per share from continuing operations was SEK 0.67 compared to SEK 1.38 a year ago. Diluted earnings per share from continuing operations was SEK 0.67 compared to SEK 1.38 a year ago.
For the full year, sales was SEK 1,296.51 million compared to SEK 1,103.96 million a year ago. Net income was SEK 365.35 million compared to SEK 373.77 million a year ago. Basic earnings per share from continuing operations was SEK 3.62 compared to SEK 3.7 a year ago. Diluted earnings per share from continuing operations was SEK 3.62 compared to SEK 3.7 a year ago.